Papillary Thyroid Carcinoma
Papillary Thyroid Carcinoma (PTC) is the most common type of thyroid cancer, accounting for around 80% of all thyroid cancer cases. It is a slow-growing cancer that affects the cells of the thyroid gland, which is a butterfly-shaped gland located in the neck. PTC is usually discovered through the detection of a lump or nodule in the thyroid gland during a routine physical examination. The exact causes of PTC are not fully understood, but certain risk factors have been identified, including exposure to radiation, genetic mutations, and certain medical conditions, such as thyroiditis. Common symptoms of PTC include a lump or nodule in the thyroid gland, difficulty swallowing, hoarseness, and swollen lymph nodes in the neck. To diagnose PTC, a biopsy of the thyroid nodule is performed, followed by imaging tests such as ultrasound, CT scan, or MRI to determine the size and location of the cancer. Treatment for PTC typically involves surgical removal of the thyroid gland, followed by radioiodine therapy to destroy any remaining cancer cells. In some cases, additional treatments such as chemotherapy or targeted therapy may be necessary. Ongoing research in hematology and oncology is focused on developing more effective treatments for PTC, as well as identifying new approaches to detecting and diagnosing the disease at an earlier stage. Advances in precision medicine and targeted therapies are also showing promise in improving outcomes for patients with PTC and other types of thyroid cancer.
← Hematology Research and Oncology Research